Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionOxothiolane nucleoside analog
Molecular Target HIV reverse transcriptase
Mechanism of ActionHIV reverse transcriptase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV-1 infected treatment-naïve male patients; Treat HIV-infected treatment-experienced patients with M184V mutation
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today